PoS 2
ePoster 01

Programm

• • ePoster
  • P194

  Allodynia in migraineurs with idiopathic epilepsy is associated with headache and seizure triggers

  • Esme Ekizoğlu (Istanbul, TR)
• • ePoster
  • P195

  Persistent familial hemiplegic migraine sensorimotor aura due to PRRT2 gene deletion: the first case report

  • Gabriele Garascia (Trieste, IT)
• • ePoster
  • P196

  Plasma level of calcitonin gene-related peptide (CGRP) in the diagnosis of episodic migraine with comorbid conditions

  • Olga Dubenko (Kharkiv, UA)
• • ePoster
  • P197

  The significance of the circadian time of administration on the effectiveness and tolerability of OnabotulinumtoxinA for chronic migraine prophylaxis

  • Emmanouil Dermitzakis (Thessaloniki, GR)
• • ePoster
  • P198

  Long-term evolution of white matter structural changes in migraine patients

  • Álvaro Planchuelo-Gómez (Cardiff, GB)
• • ePoster
  • P199

  The relationship between serum vitamin D levels and the severity of headache in adult with migraine

  • Hossam Younis (Jeddah, SA)
• • ePoster
  • P200

  Differential expression of components of the CGRP-receptor family in human coronary and human middle meningeal arteries

  • Tessa de Vries (Rotterdam, NL)
• • ePoster
  • P201

  Measuring circulating plasma CGRP, PACAP and VIP levels in control and patients with migraine

  • Ayodeji A. Asuni (Copenhagen, DK)
• • ePoster
  • P202

  Miniscope-based blood vessel imaging enables a novel assay for migraine therapeutic concept testing

  • Ayodeji A. Asuni (Copenhagen, DK)
• • ePoster
  • P203

  CGRP and calcitonin receptor expression in the amygdala of rats and mice

  • Debbie Hay (Dunedin, NZ)
• • ePoster
  • P205

  Phenotyping migraine patients according to clinical and psychophysical characteristics: a cluster analysis approach (Part 1)

  • Stefano Di Antonio (Aalborg, DK)